Home Cart Sign in  
Chemical Structure| 909089-13-0 Chemical Structure| 909089-13-0

Structure of SKL2001
CAS No.: 909089-13-0

Chemical Structure| 909089-13-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SKL2001 is Wnt/β-catenin pathway agonist which interferes in the interaction of Axin/β-catenin.

Synonyms: Wnt Agonist II; SKL2001

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SKL2001

CAS No. :909089-13-0
Formula : C14H14N4O3
M.W : 286.29
SMILES Code : O=C(C1=NOC(C2=CC=CO2)=C1)NCCCN3C=CN=C3
Synonyms :
Wnt Agonist II; SKL2001
MDL No. :MFCD14733081
InChI Key :PQXINDBPUDNMPE-UHFFFAOYSA-N
Pubchem ID :16003447

Safety of SKL2001

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
cultured blastema cells 40 μM 24 h To test the effect of SKL2001 on Akt phosphorylation, it was found that SKL2001 treatment enhanced Akt phosphorylation. PMC9515156
mouse primary chondrocytes 40 μM 15 h SKL2001, as an agonist of the Wnt/β-catenin pathway, was used to reverse the effect of IL-1β on the Wnt/β-catenin pathway. The results showed that SKL2001 significantly inhibited the cell viability of microsphere-treated IL-1β-stimulated chondrocytes and increased cell apoptosis. PMC11513804
THP-1 macrophages 20 µM 1 h To verify the effect of SKL2001 on the expression of β-catenin and c-Myc in THP-1 macrophages, the results showed that SKL2001 increased the expression of β-catenin and c-Myc. PMC10797692
CRC cells 30 μM 24 h To investigate the role of β-catenin signaling in the regulation of TFAM expression in CRC cells, 30 μM SKL2001 was added into cell culture medium for 24h. The results showed that SKL2001 significantly upregulated the expression of TFAM. PMC8360642
Human memory CD8+ T cells 20 μM 7 days SKL2001 mildly suppressed cell proliferation, increased the expression of CD27, CD28, and CD62L, while decreasing the expression of KLRG1, indicating it generates more TCM cells through the Wnt pathway. PMC8759796
Human memory CD8+ T cells 20 μM 7 days SKL2001 significantly increased the proportion of IL-2+ cells and enhanced polyfunctionality, indicating it enhances the polyfunctionality of memory CD8+ T cells through the Wnt pathway. PMC8759796

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.49mL

0.70mL

0.35mL

17.46mL

3.49mL

1.75mL

34.93mL

6.99mL

3.49mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories